1-7 of 7
Mark Davis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Single Centre Cohort Study of Monitoring B Cell Populations in the Bone Marrow and Peripheral Blood Post Tisagenlecleucel Therapy of Relapsed/Refractory Acute Lymphoblastic Leukaemia

Sneha Fernandes, Archana Rauthan, Macarena Oporto Epuelas, Katherine Berry, Saskia Burridge, Charlotte Twigdon-Williams, Christopher Connor, Mark Davis, Kimberly Gilmour, Rebecca Thomas, Phil Ancliff, Jack Bartram, Robert Chiesa, Giovanna Lucchini, Vesna Pavasovic, Anupama Rao, Kanchan Rao, Sujith Samarasinghe, Juliana Silva, Ajay Vora, Persis Amrolia, Sara Ghorashian
Journal: Blood
Blood (2023) 142 (Supplement 1): 3508.
https://doi.org/10.1182/blood-2023-182730
Published: 2023
Journal Articles

Over 4 Years of Safety and Efficacy with Voxelotor Treatment for Patients with Sickle Cell Disease: Updated Results from an Open-Label Extension of the Phase 3 HOPE Trial

Maureen Okam Achebe, Hoda MA Hassab, Salam Al-Kindi, Clark Brown, Paul Telfer, Bart J. Biemond, Thokozeni Lipato, Mark Davis, Sarah Gray, Victor R. Gordeuk
Journal: Blood
Blood (2023) 142 (Supplement 1): 2527.
https://doi.org/10.1182/blood-2023-188616
Published: 2023
Journal Articles

Insights into Vaso-Occlusive Crises-Related Readmissions in Patients with SCD across Geographic Regions

Raffaella Colombatti, Carolyn Hoppe, Elliott P. Vichinsky, Mona Hamdy, Adeseye Michael Akinsete, Mark Davis, Halima Bello-Manga, Iheanyi Okpala, Ana Cristina Silva Pinto, Adlette Inati
Journal: Blood
Blood (2022) 140 (Supplement 1): 5453–5455.
https://doi.org/10.1182/blood-2022-167948
Published: 2022
Journal Articles

Trials in Progress: Two Randomized, Double-Blind, Multicenter, Placebo-Controlled Trials Investigating the Efficacy of Voxelotor on Cerebral Blood Flow and Neurocognitive Function in Patients with Sickle Cell Disease

Melanie E. Fields, Kaitlin L Strumph, Manus J. Donahue, Mark Davis, Cesar Cisneros, Stephanie Bell, David Purdie, Emily Riehm Meier, Allison A. King
Journal: Blood
Blood (2022) 140 (Supplement 1): 2537–2538.
https://doi.org/10.1182/blood-2022-168246
Published: 2022
Journal Articles

Preliminary Results of a Phase 1 Study in Healthy Subjects Administered Inclacumab, a Fully Human IgG4 Anti-P-Selectin Monoclonal Antibody in Development for Treatment of Sickle Cell Disease

Christina Mayer, Daniel Scott Cooper, Andrew Redfern, Xin Geng, Jianxia Shi, Mariëlle van Zutphen-van Geffen, Isabelle Kuan, Kathleen Koeck, Helen Kastrissios, Kashyap Patel, Mark Davis, Patrick Yue
Journal: Blood
Blood (2021) 138 (Supplement 1): 977.
https://doi.org/10.1182/blood-2021-153370
Published: 2021
Journal Articles

Maria: Accurate Prediction of MHC-II Peptide Presentation with Deep-Learning and Lymphoma Patient MHC-II Ligandome

Binbin Chen, BS, Michael Khodadoust, MD PhD, Niclas Olsson, PhD, Ethan Fast, BS, Lisa E Wagar, PhD, Chih Long Liu, PhD, Mark Davis, PhD, Ronald Levy, MD, Joshua E Elias, PhD, Russ B Altman, MD PhD, Arash A. Alizadeh, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1486.
https://doi.org/10.1182/blood.V130.Suppl_1.1486.1486
Published: 2017
Journal Articles

New Approaches to Human Immunology

Mark Davis, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): SCI-47.
https://doi.org/10.1182/blood.V130.Suppl_1.SCI-47.SCI-47
Published: 2017